GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (STU:PKN) » Definitions » Cyclically Adjusted PB Ratio

Revvity (STU:PKN) Cyclically Adjusted PB Ratio : 2.92 (As of May. 27, 2024)


View and export this data going back to 1983. Start your Free Trial

What is Revvity Cyclically Adjusted PB Ratio?

As of today (2024-05-27), Revvity's current share price is €103.40. Revvity's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €35.40. Revvity's Cyclically Adjusted PB Ratio for today is 2.92.

The historical rank and industry rank for Revvity's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:PKN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.09   Med: 3.91   Max: 8.04
Current: 2.96

During the past years, Revvity's highest Cyclically Adjusted PB Ratio was 8.04. The lowest was 2.09. And the median was 3.91.

STU:PKN's Cyclically Adjusted PB Ratio is ranked worse than
67.41% of 135 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.93 vs STU:PKN: 2.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Revvity's adjusted book value per share data for the three months ended in Mar. 2024 was €58.455. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €35.40 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Revvity Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Revvity's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Cyclically Adjusted PB Ratio Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.73 6.55 7.70 4.47 2.99

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.04 3.46 3.10 2.99 2.75

Competitive Comparison of Revvity's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted PB Ratio falls into.



Revvity Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Revvity's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=103.40/35.4
=2.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Revvity's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=58.455/131.7762*131.7762
=58.455

Current CPI (Mar. 2024) = 131.7762.

Revvity Quarterly Data

Book Value per Share CPI Adj_Book
201406 13.406 100.560 17.568
201409 14.170 100.428 18.593
201412 14.724 99.070 19.585
201503 16.815 99.621 22.242
201506 16.671 100.684 21.819
201509 16.357 100.392 21.471
201512 17.293 99.792 22.835
201603 16.882 100.470 22.142
201606 16.989 101.688 22.016
201609 17.374 101.861 22.477
201612 18.625 101.863 24.095
201703 18.800 102.862 24.085
201706 19.696 103.349 25.114
201709 19.307 104.136 24.432
201712 19.166 104.011 24.282
201803 18.734 105.290 23.447
201806 19.462 106.317 24.123
201809 19.846 106.507 24.555
201812 20.545 105.998 25.541
201903 21.057 107.251 25.872
201906 21.568 108.070 26.299
201909 22.124 108.329 26.913
201912 22.786 108.420 27.695
202003 22.439 108.902 27.152
202006 23.633 108.767 28.632
202009 24.524 109.815 29.428
202012 27.394 109.897 32.848
202103 30.000 111.754 35.375
202106 31.413 114.631 36.111
202109 46.869 115.734 53.365
202112 50.063 117.630 56.084
202203 51.730 121.301 56.197
202206 53.718 125.017 56.622
202209 56.535 125.227 59.492
202212 55.182 125.222 58.070
202303 59.561 127.348 61.632
202306 58.417 128.729 59.800
202309 58.448 129.860 59.311
202312 58.491 129.419 59.556
202403 58.455 131.776 58.455

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Revvity  (STU:PKN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Revvity Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Revvity's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (STU:PKN) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity (STU:PKN) Headlines